Jacek Mackiewicz
Overview
Explore the profile of Jacek Mackiewicz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
72
Citations
1351
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Szostak N, Budnik M, Tomela K, Handschuh L, Samelak-Czajka A, Pietrzak B, et al.
Cancer Immunol Immunother
. 2025 Feb;
74(4):110.
PMID: 39998665
Research has shown that the microbiome can influence how the immune system responds to melanoma cells, affecting the course of the disease and the outcome of the therapy. Here, we...
2.
Yoon C, Ross M, Gastman B, Luke J, Ascierto P, Long G, et al.
Ann Surg Oncol
. 2025 Feb;
32(4):2756-2764.
PMID: 39893343
Background: Previous results from the KEYNOTE-716 trial demonstrated significantly improved recurrence-free survival (RFS) and distant metastasis-free survival (DMFS) with adjuvant pembrolizumab versus placebo in patients with resected stage IIB or...
3.
Rosciszewska-Zukowska I, Kulakowska A, Kalinowska A, Bartosik-Psujek H, Mirowska-Guzel D, Stasiolek M, et al.
Neurol Neurochir Pol
. 2025 Jan;
59(1):20-32.
PMID: 39811975
Multiple sclerosis (MS) is an autoimmune demyelinating disease of the central nervous system (CNS) that is usually diagnosed between the ages of 20 and 40. Changes in the immune system...
4.
Kolenda T, Guglas K, Stasiak M, Poter P, Kozlowska-Maslon J, Bialas P, et al.
EXCLI J
. 2025 Jan;
23:1375-1396.
PMID: 39764216
Cutaneous melanoma is the deadliest form of skin cancer. Despite advancements in treatment, many patients still face poor outcomes. A deeper understanding of the mechanisms involved in melanoma pathogenesis is...
5.
Drymel B, Tomela K, Galus L, Olejnik-Schmidt A, Mackiewicz J, Kaczmarek M, et al.
Int J Mol Sci
. 2024 Dec;
25(23).
PMID: 39684692
An accumulating number of studies suggest the potential of circulating cell-free microbial DNA (cfmDNA) as a non-invasive biomarker in various diseases, including cancers. However, its value in the prediction or...
6.
Galus L, Kolenda T, Michalak M, Mackiewicz J
Heliyon
. 2024 Apr;
10(7):e29071.
PMID: 38601651
Melanoma is a cancer with a high incidence rate that, despite the significant development of therapeutic options, still remains a major problem. The identification of biomarkers to select the right...
7.
Calik J, Calik K, Sauer N, Zdzislaw B, Giedziun P, Mackiewicz J, et al.
Cancers (Basel)
. 2024 Mar;
16(6).
PMID: 38539459
This study investigates the impact of bisphosphonate therapy on the stomatognathic system in 80 patients with cancer of the breast and prostate with bone metastases. Bisphosphonates are integral for managing...
8.
Schadendorf D, Luke J, Ascierto P, Long G, Rutkowski P, Khattak A, et al.
J Immunother Cancer
. 2024 Mar;
12(3).
PMID: 38485189
Background: Adjuvant pembrolizumab significantly improved recurrence-free survival (RFS) and distant metastasis-free survival (DMFS) versus placebo in the phase 3 KEYNOTE-716 study of resected stage IIB or IIC melanoma. At the...
9.
Luke J, Ascierto P, Khattak M, de la Cruz Merino L, Del Vecchio M, Rutkowski P, et al.
J Clin Oncol
. 2024 Mar;
42(14):1619-1624.
PMID: 38452313
JCO Pembrolizumab adjuvant therapy was shown to significantly improve recurrence-free survival (RFS) and distant metastasis-free survival (DMFS) in patients with resected stage IIB or IIC melanoma in earlier analyses of...
10.
Calik J, Zawada T, Bove T, Dziegiel P, Pogorzelska-Antkowiak A, Mackiewicz J, et al.
J Clin Med
. 2024 Feb;
13(4).
PMID: 38398246
: High-Intensity Focused Ultrasound (HIFU) has emerged as a precise and non-invasive modality for tissue ablation and healing. This study presents a detailed dermoscopic analysis of skin healing post-High-Intensity Focused...